| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6174123 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2013 | 6 Pages |
Abstract
Patients 30 years of age and older have a higher risk of LSIL progression or persistence as compared to 20-29 year olds. In addition, HPV genotyping, but not the cell cycle markers, may aid in prognosis of LSIL course.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Koen D. Quint, Maurits N.C. de Koning, Wim G.V. Quint, Edyta C. Pirog,